Intellia Therapeutics, Inc.

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ NTLA
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/14/2026
Shares
34,482
Value ($000)
442
Weight
0.0%
2025 Q4 - 2026 Q1 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).